PMV Pharmaceuticals, Inc is a biotechnology business based in the US. PMV Pharmaceuticals shares (PMVP) are listed on the NASDAQ and all prices are listed in US Dollars. PMV Pharmaceuticals employs 44 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in PMV Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PMVP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
PMV Pharmaceuticals stock price (NASDAQ: PMVP)Use our graph to track the performance of PMVP stocks over time.
PMV Pharmaceuticals shares at a glance
|Latest market close||$34.40|
|52-week range||$28.13 - $63.22|
|50-day moving average||$33.62|
|200-day moving average||$35.61|
|Wall St. target price||$61.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy PMV Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy PMV Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PMV Pharmaceuticals price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||2.44%|
|3 months (2021-04-30)||1.99%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
PMV Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-9.32%|
|Return on equity TTM||-17.36%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
Shorting PMV Pharmaceuticals shares
There are currently 3.1 million PMV Pharmaceuticals shares held short by investors – that's known as PMV Pharmaceuticals's "short interest". This figure is 5.9% down from 3.3 million last month.
There are a few different ways that this level of interest in shorting PMV Pharmaceuticals shares can be evaluated.
PMV Pharmaceuticals's "short interest ratio" (SIR)
PMV Pharmaceuticals's "short interest ratio" (SIR) is the quantity of PMV Pharmaceuticals shares currently shorted divided by the average quantity of PMV Pharmaceuticals shares traded daily (recently around 449118.91495601). PMV Pharmaceuticals's SIR currently stands at 6.82. In other words for every 100,000 PMV Pharmaceuticals shares traded daily on the market, roughly 6820 shares are currently held short.
To gain some more context, you can compare PMV Pharmaceuticals's short interest ratio against those of similar companies.
However PMV Pharmaceuticals's short interest can also be evaluated against the total number of PMV Pharmaceuticals shares, or, against the total number of tradable PMV Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PMV Pharmaceuticals's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 PMV Pharmaceuticals shares in existence, roughly 70 shares are currently held short) or 0.1138% of the tradable shares (for every 100,000 tradable PMV Pharmaceuticals shares, roughly 114 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against PMV Pharmaceuticals.
Find out more about how you can short PMV Pharmaceuticals stock.
PMV Pharmaceuticals share dividends
We're not expecting PMV Pharmaceuticals to pay a dividend over the next 12 months.
PMV Pharmaceuticals overview
PMV Pharmaceuticals, Inc. , a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores p53 function. It is also developing p53 R273H mutation and other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013.
Stocks similar to PMV Pharmaceuticals
PMV Pharmaceuticals in the news
PMV Pharmaceuticals initiated with a Buy at H.C. Wainwright
Pmv Pharmaceuticals Inc (PMVP) President and CEO David Henry Mack Sold $993,707 of Shares
Where Do Hedge Funds Stand On PMV Pharmaceuticals, Inc. (PMVP)?
Frequently asked questionsWhat percentage of PMV Pharmaceuticals is owned by insiders or institutions?
Currently 11.948% of PMV Pharmaceuticals shares are held by insiders and 87.144% by institutions. How many people work for PMV Pharmaceuticals?
Latest data suggests 44 work at PMV Pharmaceuticals. When does the fiscal year end for PMV Pharmaceuticals?
PMV Pharmaceuticals's fiscal year ends in December. Where is PMV Pharmaceuticals based?
PMV Pharmaceuticals's address is: 8 Clarke Drive, Cranbury, NJ, United States, 08512 What is PMV Pharmaceuticals's ISIN number?
PMV Pharmaceuticals's international securities identification number is: US69353Y1038
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert